HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Colgate on pricing

This article was originally published in The Rose Sheet

Executive Summary

Colgate toothpaste price increases slated for mid-year will occur regardless of whether Procter & Gamble does the same with Crest, Colgate CEO Ian Cook informed analysts during Goldman Sachs Consumer Products Conference May 12. "We feel the brand can support it, and the costs on the business suggest a need for it," he said. He added that it seems "there is some price movement happening" with other brands. Colgate and P&G recently announced plans to raise product prices this year in order to offset higher commodity costs ( 1"The Rose Sheet" May 12, 2008, p. 6)...

You may also be interested in...



P&G, Colgate Hike Prices To Offset Rising Commodity Costs

Procter & Gamble and Colgate-Palmolive are among a number of major consumer products companies initiating price increases in order to offset rising commodity costs

On CRN Challenge, Nexus Formulas Gets Lesson On Supporting Ad Claims For Supplements

So full of errors were the firm's online ads for its Plavinol supplement, the National Advertising Division noted support for some claims contained "many of the same flaws" as others. The prevalence of problems prompted NAD to go its "scope of review" and note unclear instructions on Plavinol labels.

FDA’s Cannabidiol Crackdown: What Do Warning Letters Say About CBD In Cosmetics?

Cannabidiol (CBD) represents an intriguing opportunity for cosmetics, without the statutory obstacles faced by food and dietary supplement companies. Cosmetics marketers are taking advantage, but the FDA’s recent warning letter blitz is a reminder that CBD-infused beauty products are bound by the same rules that apply to other cosmetics.

UsernamePublicRestriction

Register

RS015432

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel